GWP GW Pharm.

TIDMGWP

RNS Number : 2809O

GW Pharmaceuticals PLC

03 November 2016

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------------------------- 
 a.   Name                            Mr Christopher Tovey 
---  ------------------------------  ----------------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------------------- 
 a.   Position/status                 Director/Chief Operating Officer 
---  ------------------------------  ----------------------------------------- 
 b.   Initial                         Initial notification 
       notification 
       /Amendment 
---  ------------------------------  ----------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------------------- 
 a.   Name                            GW Pharmaceuticals PLC 
---  ------------------------------  ----------------------------------------- 
 b.   LEI 
---  ------------------------------  ----------------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------------------- 
 a.   Description 
       of the                          Ordinary shares of 0.1p each ISIN: 
       Financial                       GB0030544687 
       instrument,                     Restricted American Depositary 
       type of                         Shares: ISIN: US36197T1372 
       instrument 
       Identification 
       code 
---  ------------------------------  ----------------------------------------- 
 b.   Nature of                      Conversion of 2,496 Ordinary shares 
       the transaction                into 208 Nasdaq listed Restricted 
                                      ADRs (12 to 1 Conversion ratio) 
---  ------------------------------  ----------------------------------------- 
 c.   Price(s)                         Price(s)   Volume(s) 
       and volume(s)                      -         208       ADRs issued upon 
                                                               conversion of 
                                                               2,496 Ordinary 
                                                               shares 
                                       ---------  ----------  ---------------- 
---  ------------------------------  ----------------------------------------- 
 d.        Aggregated 
            information 
             *    Aggregated volume    n/a 
 
 
             *    Price 
---  ------------------------------  ----------------------------------------- 
 e.   Date of                        2 November 2016 
       the transaction 
---  ------------------------------  ----------------------------------------- 
 f.   Place of                        New York 
       the transaction 
---  ------------------------------  ----------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLFEVLDLVIIR

(END) Dow Jones Newswires

November 03, 2016 09:58 ET (13:58 GMT)

Gw Pharmaceuticals (LSE:GWP)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025

Gw Pharmaceuticals (LSE:GWP)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025